In this study, while our focus did not encompass establishing causality between ﻿PDE5a inhibitors and skin cancer, we show that ﻿PDE5a inhibitor use is independently associated with skin cancer risk in individuals of European ancestries, and contributes to the high accuracy of our predictive model. This evidence concerns the gene PDE5A and skin neoplasm.